Quality of life with biweekly docetaxel and capecitabine in advanced gastro-oesophageal cancer

PURPOSE: This study aimed to evaluate the feasibility and tolerability of biweekly docetaxel with capecitabine as first-line treatment in advanced gastro-oesophageal cancer. METHODS: Fifty-three patients at median age of 61 years with advanced gastric cancer were included in this prospective, non-ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Korkeila, E. A., Salminen, T., Kallio, R., Mikkola, M., Auvinen, P., Pyrhönen, S., Ristamäki, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527066/
https://www.ncbi.nlm.nih.gov/pubmed/28424889
http://dx.doi.org/10.1007/s00520-017-3689-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527066/
https://www.ncbi.nlm.nih.gov/pubmed/28424889
http://dx.doi.org/10.1007/s00520-017-3689-5

Ejemplares similares